2009 • In EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 4 (4), p. 427-36
Silber, S., Albertsson, P., Aviles, F.F., Camici, P.G., Colombo, A., Hamm, C., Jorgensen, E., Wijns, W., Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (2005) Eur Heart J, 26, pp. 804-847
Morice, M.C., Serruys, P.W., Sousa, J.E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Falotico, R., A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revasculariza-tion (2002) N Engl J Med, 346, pp. 1773-1780
Grube, E., Silber, S., Hauptmann, K.E., Mueller, R., Buellesfeld, L., Gerckens, U., Russell, M.E., TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions (2003) Circulation, 107, pp. 38-42
Daemen, J., Serruys, P.W., Drug-eluting stent update 2007: Part I. A survey of current and future generation drug-eluting stents: Meaningful advances or more of the same? (2007) Circulation, 116, pp. 316-328
McFadden, E.P., Stabile, E., Regar, E., Cheneau, E., Ong, A.T., Kinnaird, T., Suddath, W.O., Serruys, P.W., Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy (2004) Lancet, 364, pp. 1519-1521
Camenzind, E., Steg, P.G., Wijns, W., Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern (2007) Circulation, 115, pp. 1440-1455. , discussion 1455
Morice, M.C., Serruys, P.W., Barragan, P., Bode, C., Van Es, G.A., Stoll, H.P., Snead, D., Sousa, E., Long-term clinical outcomes with sirolimus-eluting coronary stents: Five-year results of the RAVEL trial (2007) J Am Coll Cardiol, 50, pp. 1299-1304
Nordmann, A.J., Briel, M., Bucher, H.C., Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: A meta-analysis (2006) Eur Heart J, 27, pp. 2784-2814
Lagerqvist, B., James, S.K., Stenestrand, U., Lindback, J., Nilsson, T., Wallentin, L., Long-term outcomes with drug-eluting stents versus baremetal stents in Sweden (2007) N Engl J Med, 356, pp. 1009-1019
Pfisterer, M., Brunner-La Rocca, H.P., Buser, P.T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Kaiser, C., Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents (2006) J Am Coll Cardiol, 48, pp. 2584-2591
Schampaert, E., Cohen, E.A., Schluter, M., Reeves, F., Traboulsi, M., Title, L.M., Kuntz, R.E., Popma, J.J., The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) (2004) J Am Coll Cardiol, 43, pp. 1110-1115
Stone, G.W., Ellis, S.G., Cox, D.A., Hermiller, J., O'Shaughnessy, C., Mann, J.T., Turco, M., Russell, M.E., A polymer- based, paclitaxel-eluting stent in patients with coronary artery disease (2004) N Engl J Med, 350, pp. 221-231
Holmes Jr., D.R., Leon, M.B., Moses, J.W., Popma, J.J., Cutlip, D., Fitzgerald, P.J., Brown, C., Kuntz, R.E., Analysis of 1-year clinical outcomes in the SIRIUS trial: A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis (2004) Circulation, 109, pp. 634-640
Colombo, A., Drzewiecki, J., Banning, A., Grube, E., Hauptmann, K., Silber, S., Dudek, D., Russell, M.E., Randomized study to assess the effectiveness of slow- and moderaterelease polymer-based paclitaxel-eluting stents for coronary artery lesions (2003) Circulation, 108, pp. 788-794
Spaulding, C., Daemen, J., Boersma, E., Cutlip, D.E., Serruys, P.W., A pooled analysis of data comparing sirolimus-eluting stents with baremetal stents (2007) N Engl J Med, 356, pp. 989-997
Kastrati, A., Mehilli, J., Pache, J., Kaiser, C., Valgimigli, M., Kelbaek, H., Menichelli, M., Schomig, A., Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents (2007) N Engl J Med, 356, pp. 1030-1039
Stone, G.W., Moses, J.W., Ellis, S.G., Schofer, J., Dawkins, K.D., Morice, M.C., Colombo, A., Leon, M.B., Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents (2007) N Engl J Med, 356, pp. 998-1008
Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M.C., Schomig, A., Pfisterer, M.E., Juni, P., Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis (2007) Lancet, 370, pp. 937-948
James, S., (2007) Long Term Mortality after Drug-Eluting Stents in Sweden - One Additional Year of Follow-Up, , Vienna Austia: European Society Of Cardiology
Jensen, L.O., Maeng, M., Kaltoft, A., Thayssen, P., Hansen, H.H., Bottcher, M., Lassen, J.F., Thuesen, L., Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions (2007) J Am Coll Cardiol, 50, pp. 463-470
Tu, J.V., Bowen, J., Chiu, M., Ko, D.T., Austin, P.C., He, Y., Hopkins, R., Goeree, R., Effectiveness and safety of drug-eluting stents in Ontario (2007) N Engl J Med, 357, pp. 1393-1402
Mauri, L., Silverstein, T., Lovett, A., Resnic, F.S., Normand, S., (2007) Long Term Clinical Outcomes Following Drug-eluting and Bare Metal Stenting in Massachusetts, , Orlando FL: American Heart Association Scientific Sessions
Daemen, J., Van Domburg, R., Boersma, E., De Jaegere, P., Serruys, P., A long-term survival analysis of 3 sequential cohorts of consecutive all comers (n = 6129) treated with bare-metal, sirolimus- or paclitaxel-eluting stents (2007) Eur Heart J, 28 (SUPPL.), p. 325
Gershlick, A., Kandzari, D.E., Leon, M.B., Wijns, W., Meredith, I.T., Fajadet, J., Popma, J.J., Kuntz, R.E., Zotarolimus-eluting stents in patients with native coronary artery disease: Clinical and angiographic outcomes in 1,317 patients (2007) Am J Cardiol, 100 (8 B), pp. 45M-55M
Serruys, P.W., Daemen, J., Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: A nuisance in both bare metal and drug-eluting stents (2007) Circulation, 115, pp. 1433-1439. , discussion 1439
Joner, M., Finn, A.V., Farb, A., Mont, E.K., Kolodgie, F.D., Ladich, E., Kutys, R., Virmani, R., Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk (2006) J Am Coll Cardiol, 48, pp. 193-202
Nebeker, J.R., Virmani, R., Bennett, C.L., Hoffman, J.M., Samore, M.H., Alvarez, J., Davidson, C.J., Feldman, M.D., Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project (2006) J Am Coll Cardiol, 47, pp. 175-181
Virmani, R., (2006) Safety of Polymer Coating on Drug-Eluting Stents: What You Don't Know Could Kill You, , Washington DC MA: Transcather Cardiovascular Therapeutics (TCT)
Iakovou, I., Schmidt, T., Bonizzoni, E., Ge, L., Sangiorgi, G.M., Stankovic, G., Airoldi, F., Colombo, A., Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents (2005) J Am Med Assoc, 293, pp. 2126-2130
Daemen, J., Kukreja, N., Van Twisk, P.H., Onuma, Y., De Jaegere, P., Van Domburg, R., Serruys, P.W., Four-year clinical follow-up of the rapamycineluting stent evaluated at Rotterdam Cardiology hospital registry (2007) Am J Cardiol, 101, pp. 1105-1111
Daemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Serruys, P.W., Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study (2007) Lancet, 369, pp. 667-678
Cutlip, D.E., Windecker, S., Mehran, R., Boam, A., Cohen, D.J., Van Es, G.A., Steg, P.G., Serruys, P.W., Clinical endpoints in coronary stent trials - A case for standardized definitions (2007) Circulation, 115, pp. 2344-2351
Fajadet, J., Wijns, W., Laarman, G.J., Kuck, K.H., Ormiston, J., Munzel, T., Popma, J.J., Kuntz, R.E., Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholineencapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial (2006) Circulation, 114, pp. 798-806
Steg, P.G., (2007) Increased All-cause Mortality at 2 Year Follow-up after PCI with Drug-eluting Stents Vs Bare Metal Stents in Acute Coronary Syndromes: The GRACE Registry Experience, , Vienna Austria: European Society Of Cardiology
Kastrati, A., Dibra, A., Spaulding, C., Laarman, G.J., Menichelli, M., Valgimigli, M., Di Lorenzo, E., Schomig, A., Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction (2007) Eur Heart J, 22, pp. 2706-2713
Serruys, P., Daemen, J., Morice, M.C., De Bruyne, B., Colombo, A., MacAya, C., Richardt, G., Stoll, H.P., Three-year follow-up of the ARTS-II - Sirolimus-eluting stents for the treatment of patients with mul-tivessel coronary artery disease (2008) Euro Intervention, 3, pp. 450-458
Rodriguez, A.E., Maree, A.O., Mieres, J., Berrocal, D., Grinfeld, L., Fernandez-Pereira, C., Curotto, V., Palacios, I.F., Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry (2007) Eur Heart J, 28, pp. 2118-2125
Brunner-La Rocca, H.P., Kaiser, C., Bernheim, A., Zellweger, M.J., Jeger, R., Buser, P.T., Osswald, S., Pfisterer, M., Costeffectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): An 18-months analysis (2007) Lancet, 370, pp. 1552-1559. , for the BASKET Investigators
Bowen, J., Hopkins, R., Chiu, M., Blackhouse, G., Lazzam, C., Ko, D., Tu, J.V., Goeree, R., (2007) Clinical and Cost-effectiveness Analysis of Drug Eluting Stents Compared to Bare Metal Stents for Percutaneous Coronary Interventions in Ontario: Final Report [Report No. HTA002-0705-02], , http://www.path-hta.ca/report.htm, Hamilton ON: Program For Assessment Of Technology In Health St. Joseph's Healthcare HamiltonMcMaster University
. Available: http://wwwpath-htaca/ reporthtm 2007
Ong, A.T., Daemen, J., Van Hout, B.A., Lemos, P.A., Bosch, J.L., Van Domburg, R.T., Serruys, P.W., Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: Results from the RESEARCH Registry (2006) Eur Heart J, 27, pp. 2996-3003
Silber, S., Borggrefe, M., Böhm, M., Hoffmeister, H.M., Dietz, R., Ertl, G., Heush, G., Positionspapier der DGK zur Wirksamkeit und Sicherheit van Medikamente freisent-zenden Koronarstents (DES) (2007) Der Kardiol, 1, pp. 84-111
Ormiston, J.A., Serruys, P.W., Regar, E., Thuesen, L., Webster, M.W.I., Onuma, Y., Garcia-Garcia, H.M., Veldhof, S., A bioabsorbable everolimus-eluting coronary stent system for patients with singel de-novo coronary artery lesions (ABSORB): a prospective open-label trial (2008) Lancet, 371, pp. 899-907
Erbel, R., Di Mario, C., Bartunek, J., Bonnier, J., De Bruyne, B., Eberli, F.R., Erne, P., Weissman, N., Waksman R for the PROGRESS-AMS (Clinical Performance and Angiography Results of Coronary Stenting with Absorbable Metal Stents) Investigators (2007) Lancet, 369, pp. 1869-1975
Serebruany, V.L., Steinhubl, S.R., Berger, P.B., Malinin, A.I., Bhatt, D.L., Topol, E.J., Variability in platelet responsiveness to clopidogrel among 544 individuals (2005) J Am Coll Cardiol, 45, pp. 246-251
Wiviott, S.D., Braunwald, E., McCabe, C.H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.J., Antman, E.M., Prasugrel versus clopidogrel in patients with acute coronary syndromes (2007) N Engl J Med, 357, pp. 2001-2015
